Share Issue News

OMAHA, Neb.--(BUSINESS WIRE)--Boston Omaha Corporation (NYSE: BOC) (the “Company”) announced that its Board of Directors has approved and authorized a new share repurchase program (the “Share Repurchase Program”), pursuant to which the Company intends to repurchase up to $30 million of its Class A common stock. The Share Repurchase Program will become effective on November 1, 2026 and will replace the prior share repurchase program established in 2025 which would otherwise have expired on Decem...

TORONTO--(BUSINESS WIRE)--Roots Corporation (the “Company” or “Roots”) (TSX: ROOT) today announced the filing of its management information circular (the “Circular”) and related materials for the special meeting (the “Meeting”) of holders (the “Shareholders”) of common shares (the “Shares”) of Roots to approve the previously-announced plan of arrangement under the Canada Business Corporations Act (the “Arrangement”), pursuant to which Marquee Brands LLC, through its strategic operating partner...

FRISCO, Texas--(BUSINESS WIRE)--Public Storage (NYSE:PSA, the “Company”) announced today that it has priced a public offering of C$400 million aggregate principal amount of fixed-rate senior notes due 2033 (the “Notes”). This is the Company’s inaugural offering in the Canadian market, follows its recently completed acquisition of Public Storage Canada, and provides the Company another source of financing.The Notes will be issued by the Company’s finance subsidiary, PS Canada Finance ULC (“PS Can...

VANCOUVER, British Columbia & GRAPEVINE, Texas--(BUSINESS WIRE)--Alpha Cognition Inc. (NASDAQ: ACOG) (“Alpha Cognition”, “ACI”, or the “Company”), a biopharmaceutical company developing novel therapeutics for debilitating neurodegenerative disorders, today announced that on September 8, 2026, the Compensation Committee of the Company’s Board of Directors (the “Compensation Committee”) granted inducement awards consisting of nonstatutory stock options to purchase 25,000 shares of common stock to...

HAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer and inflammatory and autoimmune diseases, today announced that the Compensation Committee of the Company’s Board of Directors granted one new employee options to purchase a total of 26,350 shares of the Company’s common stock at an exercise price per share of $29.06, which was the...

SAN RAMON, Calif.--(BUSINESS WIRE)--Five9, Inc. (Nasdaq: FIVN) (“Five9” or the “Company”) today announced that on September 8, 2026, the Company granted restricted stock unit awards (“RSUs”) covering an aggregate of 104,011 shares of the Company’s common stock (“Shares”) to two non-executive officer employees (collectively, the “Inducement Awards”). The Compensation Committee of the Board of Directors of the Company approved the grant of the Inducement Awards, which were each offered as a materi...

BOTHELL, Wash.--(BUSINESS WIRE)--Immunome, Inc. (the “Company”) (Nasdaq: IMNM), a clinical-stage target oncology company focused on developing first-in-class and best-in-class targeted cancer therapies, announced today that on September 1, 2026, the Compensation Committee of the Company’s Board of Directors (the “Compensation Committee”) granted inducement awards consisting of non-statutory stock options to purchase an aggregate of 86,500 shares of common stock to four new employees under the Co...

ALISO VIEJO, Calif.--(BUSINESS WIRE)--indie Semiconductor (Nasdaq: INDI), an automotive solutions innovator, today announced that it has granted equity awards (the “Inducement Grants”) under its 2023 Inducement Incentive Plan to new employees who joined indie. The grants were previously approved by the Compensation Committee of the Board of Directors of indie Semiconductor. Information regarding the equity awards can be found on the company's investor relations website at: https://investors.ind...

NEW YORK--(BUSINESS WIRE)--Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced that the Compensation Committee of the Company’s Board of Directors approved the grant of non-qualified stock options to purchase an aggregate of 38,330 shares of the Company’s common stock to two new employees (the “Inducement Grants”) on September 1, 2026 (the “Grant Date”). The Indu...

HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nano-PFA or nsPFA™) technology, today announced that the Compensation Committee of its Board of Directors has granted equity awards to two new employees as equity inducement awards outside of the Company's 2017 Equity Incentive Plan, but under the terms of the 2017 Inducement Equity Incentive Plan. The equity awards were approved and issued...